OBJECTIVES: To test whether left ventricular (LV) dysfunction affecting type 1 diabetic-uremic patients was associated with abnormal heart high-energy phosphates (HEPs) and to ascertain whether these alterations were also present in recipients of kidney or kidney-pancreas transplantation. BACKGROUND: Heart failure is the major determinant of mortality in patients with diabetic uremia. Both uremia and diabetes induce alterations of cardiac HEPs metabolism. METHODS: Magnetic resonance imaging and phosphorous magnetic resonance spectroscopy of the LV were performed in the resting state by means of a 1.5-T clinical scanner. Eleven diabetic-uremic patients, 5 nondiabetic patients with uremia, 11 diabetic recipients of kidney transplantation, and 16 diabetic recipients of combined kidney-pancreas transplantation were studied in a cross-sectional fashion. Eleven nondiabetic recipients of kidney-only transplant and 13 healthy subjects served as control groups. RESULTS: Uremic patients had higher LV mass, diastolic dysfunction, and lower phosphocreatine (PCr)/adenosine triphosphate (ATP) ratio in comparison with recipients of kidney-pancreas or nondiabetic recipients of kidney transplant. In diabetic recipients of kidney transplant the PCr/ATP ratio was higher than in uremic patients but was lower than in the controls. Recipients of combined kidney-pancreas transplant had a higher ratio than uremic patients but no difference was found in comparison with controls. CONCLUSIONS: Altered resting myocardial HEPs metabolism may contribute to LV dysfunction in diabetic-uremic patients. In diabetic recipients of kidney transplantation, a certain degree of LV metabolic and functional impairment was found. In combined kidney-pancreas recipients the resting LV metabolism and function were not different than in controls.
OBJECTIVES: To test whether left ventricular (LV) dysfunction affecting type 1 diabetic-uremicpatients was associated with abnormal heart high-energy phosphates (HEPs) and to ascertain whether these alterations were also present in recipients of kidney or kidney-pancreas transplantation. BACKGROUND:Heart failure is the major determinant of mortality in patients with diabetic uremia. Both uremia and diabetes induce alterations of cardiac HEPs metabolism. METHODS: Magnetic resonance imaging and phosphorous magnetic resonance spectroscopy of the LV were performed in the resting state by means of a 1.5-T clinical scanner. Eleven diabetic-uremicpatients, 5 nondiabetic patients with uremia, 11 diabetic recipients of kidney transplantation, and 16 diabetic recipients of combined kidney-pancreas transplantation were studied in a cross-sectional fashion. Eleven nondiabetic recipients of kidney-only transplant and 13 healthy subjects served as control groups. RESULTS:Uremicpatients had higher LV mass, diastolic dysfunction, and lower phosphocreatine (PCr)/adenosine triphosphate (ATP) ratio in comparison with recipients of kidney-pancreas or nondiabetic recipients of kidney transplant. In diabetic recipients of kidney transplant the PCr/ATP ratio was higher than in uremicpatients but was lower than in the controls. Recipients of combined kidney-pancreas transplant had a higher ratio than uremicpatients but no difference was found in comparison with controls. CONCLUSIONS: Altered resting myocardial HEPs metabolism may contribute to LV dysfunction in diabetic-uremicpatients. In diabetic recipients of kidney transplantation, a certain degree of LV metabolic and functional impairment was found. In combined kidney-pancreas recipients the resting LV metabolism and function were not different than in controls.
Authors: E Di Cesare; F Cademartiri; I Carbone; A Carriero; M Centonze; F De Cobelli; R De Rosa; P Di Renzi; A Esposito; R Faletti; R Fattori; M Francone; A Giovagnoni; L La Grutta; G Ligabue; L Lovato; R Marano; M Midiri; A Romagnoli; V Russo; F Sardanelli; L Natale; J Bogaert; A De Roos Journal: Radiol Med Date: 2012-11-26 Impact factor: 3.469
Authors: Benno Cardini; Rupert Oberhuber; Sven R Hein; Rebecca Eiter; Martin Hermann; Markus Kofler; Stefan Schneeberger; Gerald Brandacher; Manuel Maglione Journal: J Vis Exp Date: 2017-12-16 Impact factor: 1.355
Authors: Trine Marita Reine; Ingrid Benedicte Moss Kolseth; Astri Jeanette Meen; Jørn Petter Lindahl; Trond Geir Jenssen; Finn Per Reinholt; Joseph Zaia; Chun Shao; Anders Hartmann; Svein Olav Kolset Journal: Diabetes Res Clin Pract Date: 2014-10-28 Impact factor: 5.602
Authors: Mitchell B Sally; Margaret Katherine Ellis; Michael Hutchens; Tahnee Groat; Elizabeth Swanson; Madhukar S Patel; Claus U Niemann; Darren J Malinoski Journal: Clin Transplant Date: 2019-06 Impact factor: 2.863
Authors: Maurizio Gallieni; Cristina De Salvo; Maria Elena Lunati; Antonio Rossi; Francesca D'Addio; Ida Pastore; Gianmarco Sabiu; Roberta Miglio; Gian Vincenzo Zuccotti; Paolo Fiorina Journal: Acta Diabetol Date: 2021-03-20 Impact factor: 4.280